Metformin is the regulatory-approved treatment of choice for most youth with type 2 diabetes early in the disease. However, early loss of glycemic control has been observed with metformin monotherapy.

Can you chip in? As an independent nonprofit, the Internet Archive is fighting for universal access to quality information. We build and maintain all our own systems, but we don’t charge for access, ...